406
Participants
Start Date
June 5, 2020
Primary Completion Date
February 28, 2021
Study Completion Date
February 28, 2021
Brensocatib
Selective, competitive, and reversible inhibitor of DPP1
Placebo
Matched placebo
NHS Grampian, Aberdeen
Royal United Hospitals Bath NHS Foundation Trust, Bath
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Cardiff & Vale University Health Board, Cardiff
NHS Tayside, Dundee
NHS Fife, Dunfermline
Frimley Health NHS Foundation Trust, Frimley
Princess Alexandra Hospital NHS Trust, Harlow
NHS Highland, Inverness
NHS Forth Valley, Larbert
University Hospitals of Leicester NHS Trust, Leicester
Liverpool University Hospitals NHS Foundation Trust, Liverpool
Portsmouth Hospitals NHS Trust, Portsmouth
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
University Hospitals North Midlands NHS Trust, Stoke-on-Trent
NHS Lanarkshire, Wishaw
NHS Tayside
OTHER_GOV
Insmed Incorporated
INDUSTRY
University of Dundee
OTHER